Humans have spent thousands of years experimenting with weight loss aids. While Ozempic and Wegovy may be generating ...

Our editors also may be in touch with follow-up questions. Metformin is a prescription medication for type 2 diabetes and has been a first-line treatment since its approval by the U.S. Food and ...

Metformin is often the first medicine you’ll take if you have type 2 diabetes—for many reasons. It helps bring down your blood sugar level in three ways: It tells your liver to make less ...

The increasing popularity of weight loss drugs like Wegovy, Ozempic, Mounjaro and metformin may have you wondering how all these options stack up. Are there benefits to one over the other?

Metformin is used to help treat type 2 diabetes. Mild side effects, such as nausea, vomiting, and diarrhea, are common and go away with time. But, some serious side effects may require medical ...

Foods to avoid while taking metformin include high-sugar foods, high-sodium foods, processed foods, fatty foods, and alcohol. Instead, it's best to focus on lean proteins, foods with fiber ...

Objective: To evaluate the effect of metformin on blood pressure and insulin sensitivity in non-diabetic, moderately obese, hypertensive patients. Patients and Methods: An 8-week double-blind ...

Objective Many societies recommend using estimated glomerular filtration rate (eGFR) rather than serum creatinine (sCr) to determine metformin eligibility. We examined the potential impact of ...

Shortly after metformin was FDA-approved in 1995, a study published in the New England Journal of Medicine found that metformin helped to lower fasting blood glucose by more than 20 percent.

Metformin is the most widely prescribed diabetes drug in the world. Scientists believe the drug has some colon-cancer prevention benefits. New research provides hints about its use as a ...

Following 10,117 mother-child pairs for up to 11 years after birth, researchers established that metformin provides comparable safety to insulin for both mothers and their children. This research ...